About UPMC Department of Dermatology
Clinical Trials at UPMC Department of Dermatology
During the past decade, UPMC Department of Dermatology conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "UPMC Department of Dermatology" #1 sponsor was "Pfizer" with 4 trials, followed by "LEO Pharma" with 2 trials
sponsored, "Aristea Therapeutics, Inc." with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Novartis Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC Department of Dermatology"
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UPMC Department of Dermatology
According to Clinical.Site data, the most researched conditions in "UPMC Department of Dermatology" are
"Psoriasis" (4 trials), "Atopic Dermatitis" (2 trials), "Alopecia Areata" (1 trials), "Cutaneous T-Cell Lymphoma" (1 trials) and "Cutaneous T-cell Lymphoma" (1 trials). Many other conditions were trialed in "UPMC Department of Dermatology" in a lesser frequency.
Clinical Trials Intervention Types at UPMC Department of Dermatology
Most popular intervention types in "UPMC Department of Dermatology" are "Drug" (10 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "CP-690,550" (2 trials), "Autologous Dendritic Cell Vaccine" (1 trials), "Deucravacitinib" (1 trials) and "Etrasimod" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UPMC Department of Dermatology
The vast majority of trials in "UPMC Department of Dermatology" are
11 trials for "All" genders.
Clinical Trials Status at UPMC Department of Dermatology
Currently, there are NaN active trials in "UPMC Department of Dermatology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in UPMC Department of Dermatology,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in UPMC Department of Dermatology, 1 "Phase 1"
clinical trials were conducted, 5 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".